Issue |
Section |
Title |
File |
No 9 (2018) |
Articles |
Clinical and pharmacological analysis of most commonly used drugs for the pharmacotherapy of fibrocystic breast disease |
|
No 3 (2019) |
Articles |
The impact of the thyroid and its disease on female reproductive function |
|
No 1S (2020): Supplement |
Articles |
Correction of climacteric disorders in patients with breast cancer: current methods and prospects |
|
No 12 (2021) |
Articles |
Estrogen-like and antioxidant properties of resveratrol in clinical pharmacology and therapeutic use |
|
No 12 (2021) |
Articles |
The breast and sex hormones |
|
No 12 (2021) |
Articles |
Endometriosis-associated pneumothoraxes |
|
No 2 (2023) |
Reviews |
Potentials of the current pharmacotherapy of endometriosis |
|
No 7 (2023) |
Original Articles |
Gene transcription profiles in fibrocystic breast disease |
|
No 8 (2023) |
Reviews |
Menopause in rheumatology: what is important for gynecologist to know? |
|
No 8 (2023) |
Exchange of Experience |
Experience in the clinical use of a non-hormonal vaginal cream for the treatment of genitourinary syndrome of menopause/vulvovaginal atrophy in patients with a history of estrogen-dependent oncological diseases |
|
No 9 (2023) |
Guidelines for the Practitioner |
The use of non-hormonal medications for the correction of menopausal disorders: before, instead or together with menopausal hormone therapy |
|
No 11 (2023) |
Clinical Notes |
Russian eligibility criteria for menopausal hormone therapy in patients with cardiovascular and metabolic diseases |
|
No 2 (2024) |
Clinical Notes |
The features of the course of retrocervical endometriosis |
|
No 11 (2024) |
Guidelines for the Practitioner |
Current trends in the treatment of genitourinary syndrome of menopause: the role of androgens |
|
No 12 (2024) |
Exchange of Experience |
Efficacy and safety of mifepristone in patients with uterine fibroids |
|